Jul 22, 2026 10:14 PM
Updated Jul 30, 2026 5:41 PM
Ashley Abel is cofounder at Metri Bio, which recreates human tissues in the lab to use for the development of treatments for endometrial disease. Its researchers hope to discover what drives the disease, find new drug targets and determine what potential therapies could effectively treat it. Metri Bio has $5 million in funding.
Comments
Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy